project id: TCGA-MESO; case submitter id: TCGA-MQ-A4LP; source center: 23; state: released; a260 a280 ratio: 1.85; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.34; rna integrity number: 8.6; age at index: 67; days to birth: -24652; days to death: 527; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1933; year of death: 2001; age at diagnosis: 24652; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3; ajcc staging system edition: 5th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C45.0; last known disease status: not reported; morphology: 9053/3; primary diagnosis: Mesothelioma, biphasic, malignant; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Pleura, NOS; synchronous malignancy: No; tissue or organ of origin: Pleura, NOS; tumor grade: Not Reported; year of diagnosis: 2000; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; initial weight: 410.0; sample id: 3273bab5-84d3-42ef-93c2-ee985a98fb7c; sample submitter id: TCGA-MQ-A4LP-01A; portion id: 911765ec-7824-43d6-9266-602400ec8434; portion submitter id: TCGA-MQ-A4LP-01A-11; slide id: 48983bbb-2a51-4baf-aa2a-b8a00a69904f; slide submitter id: TCGA-MQ-A4LP-01A-01-TSA; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; section location: TOP;